Completed Latvian Study Validates Machine Learning Algorithm for Prediabetes Risk Prediction in Overweight Adults

References

1. 1.American Diabetes Association. (2023). Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement_1), S19-S40. https://doi.org/10.2337/dc23-S002
2. 2.Australian Institute of Health and Welfare. (2023). Diabetes in Australia (Report No. AIHW-PHE-221). AIHW. https://www.aihw.gov.au/reports/diabetes/diabetes-in-australia
3. 3.Bergman, M. (2013). Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine, 43(2), 504-513. https://doi.org/10.1007/s12020-013-9946-8
4. 4.Cadegiani, F. A. (2019). Wearable technologies in endocrinology: a review and predictive analysis. Endocrine Practice, 25(6), 625-632. https://doi.org/10.4158/EP-2019-0031
5. 5.Goldberg, R. B., & Temprosa, M. (2013). A clinical approach to prediabetes. Current Diabetes Reports, 13(1), 102-110. https://doi.org/10.1007/s11892-013-0451-7
6. 6.Hostalek, U. (2019). Global epidemiology of prediabetes-present and future perspectives. Clinical Diabetes and Endocrinology, 5(1), 1-9. https://doi.org/10.1186/s40842-019-0080-0
7. 7.Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. Journal of Epidemiology and Global Health, 10(1), 107-111. https://doi.org/10.2991/jegh.k.191028.001
8. 8.Richter, B., Hemmingsen, B., Metzendorf, M. I., & Takwoingi, Y. (2018). Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database of Systematic Reviews, 10(10), CD012661. https://doi.org/10.1002/14651858.CD012661.pub2
9. 9.Sokolovska, J. (2024). Physics Informed Machine Learning-based Prediction and Reversion of Impaired Fasting Glucose Management [Clinical trial registration NCT06195566]. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06195566
10. 10.Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279-2290. https://doi.org/10.1016/S0140-6736(12)60283-9
11. 11.Therapeutic Goods Administration. (2021). Software as Medical Device: Guidance for manufacturers (Guidance Document TGA-GD-2021-01). TGA. https://www.tga.gov.au/resources/resource/guidance/software-medical-device-guidance-manufacturers
12. 12.Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2020). Type-1 diabetes patient decision simulator for in silico testing safety and effectiveness of insulin treatments. IEEE Transactions on Biomedical Engineering, 65(6), 1281-1290. https://doi.org/10.1109/TBME.2018.2823763